Jarle Bjelland • 1972 • Drøbak • 10 roles • 8 shareholdings

This website uses cookies to enhance the user experience.

||

Roles

Management

Name	Role	Total operating income	Total equity	Shares
O OPTICELL NORGE AS	Managing Director/CEO	16,067,698	2,175,469	100 % indirectly
V VORAX AS	Managing Director/CEO	-	1,085,794	100 % directly

Boards

Name	Role	Total operating income	Total equity	Shares
O OPTICELL NORGE AS	Chairman	16,067,698	2,175,469	100 % indirectly
V VORAX AS	Chairman	-	1,085,794	100 % directly
B BG EIENDOM II AS	Chairman	508,423	-616,889	50 % indirectly
B BJELLAND CAPITAL I AS	Chairman	-	-6,744,082	50 % indirectly
S SVEVIK AS	Chairman	365,653	-10,836,475	50 % indirectly
V VADBAKKEN VELFORENING	Contact Person	-	-	-
L LYKKE-LI BRUD AS	Board Member	106,058	-1,407,319	-

Last update: Nov 1, 2023

Related industries2

Direct relationships5

LB
Lise Bjelland Andersson1976
BG EIENDOM II AS, BJELLAND CAPITAL I AS, LYKKE-LI BRUD AS, SVEVIK AS
NB
Nina Bjerkelund Olson1980
LYKKE-LI BRUD AS
SI
Svein Ivar Stubberud1959
VADBAKKEN VELFORENING
BJ
Børre Johan Nøkleby1962
VADBAKKEN VELFORENING
CA
Christian Aschjem1966
VADBAKKEN VELFORENING

Shares owned by Jarle Bjelland

Name	Share class	Total operating income	Total equity	Share
V VORAX AS	Ordinære aksjer	0	1,085,794	100 % directly
O OPTICELL NORGE AS		16,067,698	2,175,469	100 % indirectly
B BG EIENDOM II AS		508,423	-616,889	50 % indirectly
B BJELLAND CAPITAL I AS		0	-6,744,082	50 % indirectly
S SVEVIK AS		365,653	-10,836,475	50 % indirectly
C CARDIACCS AS		355,301	1,472,752	0.88 % indirectly
P PRO WELL PLAN AS		3,776,865	5,459,940	0.69 % indirectly
G GENETIC ANALYSIS AS	NO0010692130	20,684,000	22,494,000	0.04 % directly < 0.01 %

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025